Sclerostin Quo Vadis? - Is This a Useful Long-Term Mortality Parameter in Prevalent Hemodialysis Patients?

Background/Aims: Cardiovascular calcification contributes to the increased mortality in hemodialysis patients. Sclerostin was identified as an antianabolic bone factor causing soft tissue calcification. Data on prospective large-scale studies associating sclerostin with mortality in hemodialysis pat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Albina Nowak (Autor), Ferruh Artunc (Autor), Andreas L. Serra (Autor), Emily Pollock (Autor), Pierre-Alexandre Krayenbühl (Autor), Christian Müller (Autor), Björn Friedrich (Autor)
Format: Knjiga
Izdano: Karger Publishers, 2015-05-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno